MicroRNA alterations in neuropathologic cognitive disorders with an emphasis on dementia: Lessons from animal models
- PMID: 32602584
- DOI: 10.1002/jcp.29908
MicroRNA alterations in neuropathologic cognitive disorders with an emphasis on dementia: Lessons from animal models
Abstract
Cognitive dysfunction is a state of losing or having difficulties in remembering, learning, focusing, or making decisions that impact individual healthy life. Small single-stranded and nonprotein coding RNAs, microRNAs (miRNAs) participate actively in regulatory processes, incorporate cognitive signaling pathways, and intensely affect cognitive evolution. miRNAs exert their modification activities through translational or transcriptional processes. Reportedly, cognitive impairment and dementia are rising, especially in developing countries. Herein we provided a brief review of original studies addressing miRNA changes in the most common neurological diseases with a focus on dementia and Alzheimer's disease. It must be noted that an increase in the level of certain miRNAs but a decrease in other ones deteriorate cognitive performance. The current review revealed that induction of miR-214-3p, miR-302, miR-21, miR- 200b/c, miR-207, miR-132, miR-188-3p and 5p, and miR-873 improved cognitive impairment in various cognitive tasks. On the other hand, intentionally lowering the level of miR-34a, miR-124, miR-574, and miR-191a enhanced cognitive function and memory. Synaptic dysfunction is a core cause of cognitive dysfunction; miRNA-34, miRNA-34-c, miRNA-124, miRNA-188-5p, miRNA-210-5p, miRNA-335-3p, and miRNA-134 strongly influence synaptic-related mechanisms. The downregulation of miRNA-132 aggregates both amyloid and tau in tauopathy. Concerning the massive burden of neurological diseases worldwide, the future challenge is the translation of animal model knowledge into the detection of pathophysiological stages of neurocognitive disorders and designing efficient therapeutic strategies. While the delivery procedure of agomir or antagomir miRNAs into the brain is invasive and only applied in animal studies, finding a safe and specific delivery route is a priority.
Keywords: amyloid β; cognition; dementia; memory; miRNA; tau.
© 2020 Wiley Periodicals LLC.
References
REFERENCES
-
- Ayers, D., & Scerri, C. (2018). Non-coding RNA influences in dementia. Non-coding RNA Research, 3, 188-194.
-
- Banzhaf-Strathmann, J., Benito, E., May, S., Arzberger, T., Tahirovic, S., Kretzschmar, H., & Edbauer, D. (2014). MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease. The EMBO Journal, e201387576.
-
- Barter, J. D., & Foster, T. C. (2018). Aging in the brain: New roles of epigenetics in cognitive decline. The Neuroscientist, 24(5), 516-525.
-
- Brionne, T. C., Tesseur, I., Masliah, E., & Wyss-Coray, T. (2003). Loss of TGF-β1 leads to increased neuronal cell death and microgliosis in mouse brain. Neuron, 40(6), 1133-1145.
-
- Cai, J., Schleidt, S., Pelta-Heller, J., Hutchings, D., Cannarsa, G., & Iacovitti, L. (2013). BMP and TGF-β pathway mediators are critical upstream regulators of Wnt signaling during midbrain dopamine differentiation in human pluripotent stem cells. Developmental Biology, 376(1), 62-73.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
